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Neural crest (NC) generates diverse lineages in-
cluding peripheral neurons, glia, melanocytes, and
mesenchymal derivatives. Isolating multipotent hu-
man NC has proven challenging, limiting our ability
to understand NC development and model NC-asso-
ciated disorders. Here, we report direct reprogram-
ming of human fibroblasts into induced neural crest
(iNC) cells by overexpression of a single transcription
factor, SOX10, in combination with environmental
cues including WNT activation. iNC cells possess
extensive capacity for migration in vivo, and single
iNC clones can differentiate into the four main NC lin-
eages. We further identified a cell surface marker for
prospective isolation of iNCs, which was used to
generate and purify iNCs from familial dysautonomia
(FD) patient fibroblasts. FD-iNC cells displayed de-
fects in cellular migration and alternative mRNA
splicing, providing insights into FD pathogenesis.
Thus, this study provides an accessible platform for
studying NC biology and disease through rapid and
efficient reprogramming of human postnatal fibro-
blasts.
INTRODUCTION
During development, various cellular fates in our body are
determined by intercellular signaling cascades and cell-type-
specific gene expression patterns. These cell determination
processes are often elicited by cell extrinsic factors, such as
growth factors, morphogens, and extracellular matrix, released
from neighboring cells in a spatiotemporally controlled manner.
Recent studies have shown that particular combinations of
transcription factors can force human somatic cells into new
identities, including pluripotent stem cells (Park et al., 2008;
Takahashi and Yamanaka, 2006), postmitotic neurons (Pang
et al., 2011), myoblasts (Scha¨fer et al., 1990), etc. Such geneticCefactors may be replaced by environmental elements or cell
extrinsic cues for certain cell types; for example, the formation,
proliferation, and differentiation of neural crest (NC) cells are
contingent upon and triggered by the interaction of several
signaling pathways (Sieber-Blum and Zhang, 1997), including
WNT, BMP, and FGF molecules provided by adjacent tissues,
such as neural plate, epidermis, mesodermal cells, etc. There-
fore, the direct conversion of human somatic cells into the NC
fate might be attained by environmental cues with minimal ge-
netic intervention. Here, we set out to determine whether
different cell extrinsic factors together with a single transcription
factor are sufficient to convert normal human fibroblasts
directly into induced NC (iNC), demonstrating the feasibility of
further isolation of disease-specific iNCs directly from patient
fibroblasts.
RESULTS
To identify the factors sufficient for iNC generation from fibro-
blasts, we used a Sox10::eGFP reporter human embryonic
stem cell (hESC) line (Lee et al., 2010), because SOX10 is one
of the most characterized NC genetic markers (Betancur et al.,
2010; Kelsh, 2006). This genetic reporter hESC line faithfully ex-
presses eGFP for SOX10 expression in NC differentiation (Fig-
ures S1A–S1D, available online). To confirm that the fibroblasts
are not in any ‘‘partial stem-like’’ or ‘‘intermediate differentiation’’
stages, we confirmed that their fibroblasts do not have any eGFP
expression, pluripotent stem cell marker or SOX10 expression,
and further methylation status of NANOG (Figures S1E–S1J)
before performing qRT-PCR for NESTIN (<105 compared to
hESC-derived neural progenitors) and antibody staining for
NESTIN (0 out of 1,535 cells), PAX3 (0 out of 1,516 cells), PAX6
(0 out of 1,672 cells), and PAX7 (0 out of 1,483 cells) (data not
shown). Because SOX10 is a key transcription factor for the
NC lineage (Betancur et al., 2010), we hypothesized that
SOX10 could be one of theminimal genetic factors for iNC induc-
tion. For a ‘‘tunable’’ SOX10 overexpression system, doxycy-
cline (DOX)-inducible lentiviruses containing SOX10 cDNA
were infected into the Sox10::eGFP fibroblasts (termed Sox10::
eGFP fibroblasts) (Figure 1A). After screening of various condi-
tions, we found that a combination of SOX10 overexpressionll Stem Cell 15, 497–506, October 2, 2014 ª2014 Elsevier Inc. 497
Figure 1. Cell Extrinsic Factors Can Induce
eGFP Expression in Sox10::eGFP Reporter
Fibroblasts
(A) Scheme of induced neural crest (iNC) derivation.
(B) Treatment duration of SOX10 overexpression
(Dox), extracellular matrix (ECM), and epigenetic
modifiers (epiM).
(C) Combined treatment of Dox, ECM, and epiM can
substantially induce eGFP expression in Sox10::
eGFP reporter fibroblasts.
(D) Chir99021 or BMP4 treatment during iNC in-
duction can significantly enhance the number of
eGFP-expressing cells.
(E) Representative FACS plot of Sox10::eGFP re-
porter fibroblasts after iNC induction (Day 14).
(F) FACS-purified eGFP-expressing iNCs and
hESC-NCs (inset panel) share characteristic mor-
phology and show immunoreactivity to Ki-67, AP2,
p75, and HNK1 antibodies.
(G) Expression levels of NC marker genes between
eGFP+ and eGFP populations assessed by qRT-
PCR analysis. *p < 0.05; **p < 0.01; ****p < 0.0001.
All scale bars correspond to 50 mm. n = 3–8. All
values are mean and SD. See also Figure S1.
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(FN/Lam) and epigenetic modifiers and 5-Aza-20-deoxycytidine/
Valproic acid (5-Aza/VPA) yields consistent eGFP expression
(0.45% ± 0.01%) (Figures 1B–1C and Figures S1K and S1L), a
comparable efficacy to that of other cell types (Sekiya and
Suzuki, 2011; Son et al., 2011; Vierbuchen et al., 2010).
Neural crest fate is modulated by extrinsic patterning factors,
as shown in mammalian development (Sieber-Blum, 2000) as
well as hESC studies (Lee et al., 2007). After DOX (SOX10), FN/
Lam, and 5-Aza/VPA treatment, we observed a significant in-
crease in eGFP+ cells upon exposure to WNT (Chir99021,
1.06% ± 0.08%, p < 0.0001; WNT3a, 0.56% ± 0.02%, p <
0.05) andBMP4 (1.3%±0.06%, p < 0.0001) activation (Figure 1D
and Figures S1M and S1N), while antagonists of WNT (IWP-2)
and BMP (LDN193189) inhibited induction of eGFP+ cells, which
were confirmed with multiple combination treatment experi-
ments (Figure S1O). In a time course analysis (Figure S1P),498 Cell Stem Cell 15, 497–506, October 2, 2014 ª2014 Elsevier Inc.the eGFP induction level with either
Chir99021 or BMP4 in the presence of
SOX10/FN/Lam/5Aza/VPA is comparable.
Isolated eGFP-expressing cells (Fig-
ure 1E) have morphological similarity with
hESC-derived NC cells (hESC-NC cells)
(Figure 1F and Figure S1Q), express Ki-
67, HNK1, p75, and AP2 protein
(21.75% ± 3.49%, 97.5% ± 5.59%,
73.8 ± 7.85%, and 97.2% ± 4.81%,
respectively) 24 hr after cell sorting (Fig-
ure 1F and Figure S1R), and couldmaintain
SOX10 expression (73.7% ± 15.65%) even
after 1 week of culture without DOX treat-
ment (Figures S1S and S1T). Interestingly,
the Sox10::eGFP+ cells underWNT activa-
tion, but not those under BMP activation
(Figure S1U), showed increased levels ofNC marker gene expression (Figure 1G). Antibody staining for
pSMAD1/5 shows that Sox10::eGFP fibroblasts (grown in 10%
FBS) have enough BMP activation level that is abolished by
TGF-beta inhibitors (LDN193189 and SB431542) (Figures S1V
and S1W). Furthermore, our iNC population can be propagated
in culture with multiple passages (at least 4 weeks) (Figure S1X),
demonstrating that isolated iNCs could survive without losing
proliferation ability and NC identity even after SOX10 withdrawal
(Figures 1F–1G and Figures S1S, S1T, and S1X). In addition,
using an OCT4::eGFP reporter system, we confirmed that our
iNC protocol does not contain any detectable pluripotent inter-
mediate stage (Figure S1Y).
Next, we examined the fact that NCmarker gene expression in
eGFP+ iNCs was significantly upregulated (p75, p < 0.0001;
endogenous SOX10, p < 0.0001; FOXD3, p < 0.0001) (Figure 2A
and Figure S2A), compared to the uninduced population
(Sox10::eGFP fibroblasts). Meanwhile, oligodendrocyte markers
Figure 2. Detailed Molecular Profiling of
iNCs Converted from Sox10::eGFP Fibro-
blasts
(A) Gene expression levels of Sox10::eGFP+ iNCs
(p75, endogenous SOX10 and FOXD3) are signifi-
cantly higher than those of Sox10::eGFP fibro-
blasts (before iNC induction), but comparable to
those of hESC-NCs. ****p < 0.0001.
(B) Clustered heat map of global gene expression.
(C) Single-cell gene expression analysis.
(D) Graphical representation of the methylation
state using bisulphite-sequencing analysis of the
FOXD3 promoter. n = 3–4. All values are mean and
SD. See also Figure S2.
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Derivation of Human Induced Neural CrestOLIG2, NKX2.2, and NKX6.2 were not detected (Figure S2B).
Global gene expression in FACS-purified eGFP+ putative iNC
and hESC-NC showed substantial downregulation of fibro-
blast-specific gene signatures and large-scale activation of
genes specific to the NC lineage, resulting in a hierarchical clus-
tering between hESC-NC- and eGFP-expressing iNCs over
other cell types (Figure 2B). Based on our single-cell qRT-PCRCell Stem Cell 15, 497–50analysis (Figures S2C–S2E), most of the
FACS-purified single iNC cells showed
robust expression of NC marker genes,
similar to hESC-NC, and again exhibited
hierarchical clustering between hESC-
NC-expressing and all eGFP-expressing
single iNC cells (Figure 2C). Comparison
of the gene expression profiles between
the hESC-NC and iNC populations iden-
tifies common upregulated genes, includ-
ing known NC marker genes (including
TWIST1, SNAIL2, ITGA4, ITGA6, SOX5,
SOX6, PLP1, Myelin Protein Zero [MPZ],
etc.). The differentially expressed genes
between the hESC-NC and iNC popula-
tions fall into several categories—the
upregulated gene list in iNC can be cate-
gorized according to melanocytic specifi-
cation (melanocytic differentiation: p =
0.02323, pigment cell differentiation: p =
0.02967, pigment granule/melanosome:
p = 0.0006298, pigmentation: p =
0.02088), whereas upregulated genes in
hESC-NC are largely classified into two
major categories, neuronal specification
(neuron differentiation: p = 8.52e17, cell
morphogenesis involved in neuron differ-
entiation: p = 2.40e14, sensory organ
development: p = 1.73e09) and NC
migration (NC cell migration: p =
0.03795, migration: p = 0.01590). Further-
more, we monitored the DNA methylation
status of two regions in FOXD3 (Wahlbuhl
et al., 2012), which showed drastic
changes in the DNA methylation profile
after iNC induction (Figure 2D). These
data demonstrate that Sox10::eGFP-ex-pressing iNCs obtain genetic and epigenetic similarity to
hESC-NC, but not to fibroblasts or undifferentiated hESCs, in
both a bulk and a single-cell manner.
To characterize cellular features as an NC, first we investi-
gated the increasedmigration ability ofSox10::eGFP-expressing
iNC over GFP() non-iNC populations (Figure S3A). To find their
in vivo behaviors, freshly isolated iNC populations were grafted6, October 2, 2014 ª2014 Elsevier Inc. 499
(legend on next page)
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Derivation of Human Induced Neural Crestinto the intersomite space of chick embryos (Lee et al., 2007)
after being labeling with DiI dye (Figures 3A–3B and Figure S3C)
or GFP (Figures 3C–3E, negative control shown in Figure S3B),
and human cells were identified by either DiI dye or antibodies
against GFP or human-specific markers (Figure 3A and Fig-
ure S3C). Two days after in ovo transplantation, we observed
extensivemigration of the iNC population throughout the embryo
(Figures 3A and 3B). More importantly, 3 days after in ovo injec-
tion, we foundmuchmore efficientmigration into the Dorsal Root
Ganglia (DRG) region, where most of the GFP-labeled iNC pop-
ulation express BRN3A and TUJ1 (Figures 3C and 3D). As shown
in Figures 3E–3F and Figure S3C, most of the transplanted iNC
cells migrated into or resided in the expected regions, such as
lateral part, DRG, Sympathetic Ganglia (SG), and enteric region.
Because we found that the numbers of transplanted iNC cells
migrating into ventral or gut region are relatively few (Figures
3E–3F and Figure S3C), we treated them with retinoic acid (RA)
(Kawaguchi et al., 2010), but still there were small numbers of
iNC that successfully migrated into developing gut (Figure 3F,
total counted iNC number = 1,593). To find their enteric neuron
commitment, we employed ex vivo coculture of iNC population
with developing chicken guts. GFP+ iNC cells are populated
near both ends of the gut and they have a typical ‘‘locomotion-
cell morphology’’ (Figure 3G), suggesting that they are a presum-
ably migrating population. We also found extensive numbers of
GFP+ iNC cells in the myenteric plexus layer and near submuco-
sal plexus layer with TUJ1 coexpression (Figure 3H), as well as
neuronal nitric oxide synthase (nNOS) and vasoactive intestinal
peptide (VIP) (Figure 3I) in the cryosection. In addition, we could
find glial specification of cocultured GFP+ iNC, determined by
GFAP staining (Figure S3D), but the percentage of GFAP+ cells
are minimal (less than 1% among GFP+ iNC). Next, we assessed
the in vitro differentiation potential of Sox10::eGFP+ iNCs upon
withdrawal of SOX10 overexpression (Figure S3E). Neuronal
differentiation was induced (Lee et al., 2010), and most of the
surviving cells after neuronal differentiation are positive for
TUJ1 (data not shown), BRN3A, Peripherin, Neurofilament,Figure 3. Differentiation Potential of iNCs Converted from Sox10::eGF
(A–E) Representative images of in ovo transplanted iNCs labeled with DiI dye (red,
Arrows in the top of (A) (red) and (C) (green) show the injection site. The yellow box
(for 48 hr) DiI+ iNC population (A) was double-confirmed with GFP, human-m
(hNCAM) (A). Migratory stream of injected iNC population (red, DiI) is overlapped w
a GFP-labeled iNC population expressing BRN3a, hNCAM, and TUJ1 (C), costain
migrated into the developing gut region (E). NT, neural tube; NC, notochord; Ao,
(F) Comparison of iNC migration/targeting region after in ovo transplantation wit
(G–I) Representative images of ex vivo coculture of embryonic developing gut
observed (G, large image), and magnified morphology of iNC was shown (in right
transverse and longitudinal sections (H), and enlarged images show expression
(J) Representative images of differentiated iNCs stained with peripheral neuron m
(K and L) Functional characterization of iNC-derived neurons, including current-
administration (L).
(M and N) Differentiation of iNC into Schwann cells (M) and melanocytes (N) with
(O–T) iNCs were differentiated into mesenchymal lineages. Representative image
marker (CD44 andCD73) (P), are shown. Sublineage differentiation into adipocytes
cells (T, upper) was confirmed with histocytochemistry or antibody staining, follow
image).
(U–X) Clonal analysis with single iNC cells, illustrated in (U). (V–X) Proportion of the
and each lineage marker (X). Representative images are for neurons, glia, smoot
Scale bars correspond to 50 mm for (A), (B), and (J–N) (except for Synapsin, whic
(O–X). See also Figure S3.
CeMAP2, Substance-P, Calcitonin Gene Related Peptide (CGRP),
and Synapsin (Figure 3J and Figure S3F), which was confirmed
again with qRT-PCR analysis forNGN2 andBRN3a (Figure S3G).
In particular, the I-V curve data (Figures 3K and 3L) demonstrate
that Sox10::eGFP-fibroblast-iNC-derived neurons have a sub-
stantial amount of sodium channels and conduct current at a
series of holding voltages in a manner comparable to that of
rodent sensory neurons. Schwann cell differentiation from
iNCs, as assessed by the expression of S100B, MPZ, and
GFAP, was induced (Lee et al., 2010) (over 95% cells were
GFAP+/S100B+) (Figure 3M) and corresponds to significant
upregulation of Schwann cell lineage markers such as DHH
and GFAP (Figure S3H). Likewise, isolated iNCs that differenti-
ated into melanocytes (Mica et al., 2013) that express MITF,
Premelanosome Protein, TRP1, and Tyrosinase (TYRS) (over
90% cells were positive) also showed a marked increase of
melanocyte-specific marker expression, including TYRS and
MITF, in comparison to Sox10::eGFP fibroblasts and freshly
isolated iNCs (Figure 3N and Figure S3I). Most of the SOX10::
eGFP+ iNC-derivedmesenchymal cells (Lee et al., 2007) showed
a typical morphology (Figure 3O) and express traditional mesen-
chymal cell surface markers (CD44 and CD73) (over 98%) (Fig-
ure 3P). Furthermore, we found that iNC-derived mesenchymal
cells could differentiate into adipogenic, chondrogenic, osteo-
genic and smooth muscle cells as assessed by appropriate
histocytochemistry/immunofluourescence and transcriptional
analysis (Figures 3Q–3T).
To find their multipotency at a single-cell level, 34 clones of
single iNC cells from hESC-derived fibroblasts were expanded,
differentiated, and analyzed (two independent repeats; Fig-
ure 3U). After their differentiation toward the four lineages, we
stained them with GFP antibody and each lineage marker
(TUJ1 for neurons, GFAP for glia, SMA for smooth muscle cells,
and MITF for melanocytes) and could address the differentiation
potentials of clones of each iNC as shown in Figures 3V–3W. Sur-
prisingly, we found that about 40% of single iNC clones from
hESC-derived fibroblasts could give rise to four differentP Reporter Fibroblasts
A and B) or GFP labeling (green, C–E) with viral transduction after iNC isolation.
es in the left panels (A and C) mark the area enlarged in other panels. Migrated
itochondria-specific antibody (hMito), and human-specific NCAM antibody
ith endogenous host (chicken) NC (HNK1, green) (B). After 72 hr after injection,
ed with HNK1 antibody (D), was located in DRG. A GFP-labeled iNC population
aorta; DRG, dorsal root ganglion.
h or without retinoic acid (RA) treatment. Ent, enteric region; IS, injection site.
with FACS-purified iNCs. After 4 days of coculture, GFP-labeled iNCs were
bottom of G). (H and I) iNCs (green) were colabeled with TUJ1 (red), shown in
of VIP and nNOS in GFP+ iNC neurons (I).
arkers.
voltage curve (I-V curve, K) and the action potentials, upon high levels of KCl
marker expression.
s of mesenchymal cellular morphology (O), and FACS plot with mesenchymal
(Q, upper), chondrocytes (R, upper), osteocytes (S, upper) and smoothmuscle
ed by specific marker gene expression for each lineage (lower panels in each
multipotency level among iNC clones (V andW), based on coexpression of GFP
h muscle cells, and melanocytes, respectively.
h indicates 10 mm); 500 mm for (C) and (D); and 100 mm for (E), (G), (H), (I), and
ll Stem Cell 15, 497–506, October 2, 2014 ª2014 Elsevier Inc. 501
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Derivation of Human Induced Neural Crestlineages (Figures 3W–3X) (‘‘quadpotent’’), whereas about 35%of
single iNC clones from hESC-derived fibroblasts are competent
to become three lineages (tripotent). This result is comparable to
our previous hESC-NC study (Lee et al., 2007), in which an
average of 65% of FACS-purified p75+/HNK1+ single cells
differentiated into triple lineages (neurons, glia, and smoothmus-
cle cells). Taken together, these experiments show the in vivo
and in vitro evidences for migration ability and multilineage
differentiation potential (even at the clonal level) of isolated
SOX10::eGFP+ iNCs.
Because p75 is already expressed in postnatal fibroblasts (Fig-
ures S4A–S4D), we profiled the known NC cell surface marker
expression in postnatal fibroblasts before and after iNC induc-
tion, and we found that one CD marker (CD34) is not expressed
before iNC induction but is present at the final stage of iNC induc-
tion (Figures S4C and S4D). We also confirmed the absence of
SOX10 expression in each postnatal fibroblast by single-cell
qRT-PCR while they expressed Collagen (Figure S4E). NC cells
and their progeny express CD34 in different postnatal tissues
(Chenet al., 2012;Yoshidaet al., 2006), and thismarker is also ex-
pressed in iNC population derived from Sox10::eGFP fibroblasts
(Figure S4F). Although CD34 is also known for expression in the
hematopoietic lineages, we could not find any evident hemato-
poietic marker gene expression (Figure S4G). Comparable effi-
ciency of CD34+ cells after iNC induction of postnatal fibroblasts
(GM00498, 3.32% ± 0.16%; GM05756, 4.99% ± 1.47%) was
achieved (Figure 4A and Figure S4H). A higher level of NCmarker
gene expression was detected in CD34+ iNCs as opposed to the
level in postnatal fibroblasts (before induction) (Figure S4I, upper
panel). Detailed transcriptional comparison (Figure 4B) with
differentially expressed genes and hierarchical analysis shows
that hESC-fibroblast-derived iNC (Sox10::eGFP+ population;
e-iNC) and postnatal-fibroblast-derived iNC (CD34+ population;
p-iNC) are clustered to each other, rather than to hESC-NC
population or undifferentiated hESCs. The list of commonly and
significantly upregulated genes between e-iNC (Sox10::eGFP+Figure 4. Direct Conversion of Human Normal and Patient Postnatal F
(A) Representative FACS plot of CD34 antibody staining before and after iNC ind
(B) Clustered heat map of global gene expression of four samples including iNC
(iNC), hESC-NC, and undifferentiated hESCs (hESC).
(C) Differentiation of postnatal iNC into neuron markers.
(D and E) Functional characterization of postnatal iNC-derived neurons, includin
levels of KCl administration (E).
(F) Differentiation of iNC into Schwann cells with expression of GFAP, S100B, Pe
(G) Differentiation potentials of postnatal iNC into melanocyte lineage, stained w
(H and I) Postnatal CD34+ iNC could differentiate into mesenchymal cells with ty
(J–M) Sublineage differentiation into adipocytes (J), chondrocytes (K), osteocyte
(N) GFP-labeled postnatal iNC was located in DRG with expression of BRN3a an
(O) Migration/targeting regions of postnatal iNC with or without RA treatment.
(P) Representative images of ex vivo coculture of embryonic developing gut with p
VIP, and nNOS).
(Q–S) Percentage of the different multipotency levels among individual postnata
Representative images are shown for neurons, glia, smooth muscle cells, and m
(T) Decreases in the percentage levels of CD34 in FD fibroblasts as compared to
(U) Wild-type (WT) IKBKAP transcript was found in CD34+ iNCs from healthy d
IKBKAP was not detected, but mutant (MU) IKBKAP was expressed. Additional q
the two populations (V).
(W) A transwell assay shows the defective migration ability of FD-iNC.
(X) Alternatively spliced transcripts of MEF2C and PAX3. The size of the PCR pro
All values are mean and SD. *p < 0.05; **p < 0.01; ***p < 0.0005; ****p < 0.0001. S
indicates 10 mm) and 10 mm for (H)–(S). See also Figure S4.
Cepopulation) and p-iNC (CD34+ population) includes early NC
markergenes (PAX3,ZIC1,FOXD3,TLX,MSX2, andTWIST), sen-
sory neuronmarker genes (NEUROG1,NEUROD1,POU4F1, and
ISL1), Schwann cell marker genes (MPZ), melanocyte marker
genes (DCT and TYRP1), etc. (Figure S4J). Interestingly, compar-
ison of gene ontology analysis with both e-iNC (SOX10::eGFP+)
and p-iNC (CD34+) shows that pigment granule (p = 3.22e04)
related and melanosome (p = 3.22e04) related genes are
upregulated in CD34+ p-iNC. Furthermore, we differentiated
CD34+ p-iNC into peripheral neurons and Schwann cells. Even
though 20% of cells were dead during neuronal differentiation,
85% of survived cells were TUJ1+ cells (data not shown). As
shown in Figure 4C, p-iNC-derived neurons express BRN3a,
Peripherin, MAP2, Synaptophysin, and Synapsin. The electro-
physiological recordings revealed that those p-iNC derived
neurons are functional (Figures 4D and 4E), exhibiting action
potentials with current injection and high levels of potassium
treatment. For Schwann cell differentiation, sorted p-iNC was
subject to the culture condition, same as in Figure S3E. Three
weeks after culture, we could find strong immunoreactivity of
Schwann cells markers, GFAP, periaxin (PRX), MPZ, and
S100B, in most of the cells (90%) (Figure 4F). Melanocytes were
also achieved and confirmed by antibody staining with the spe-
cificmarkersMITFandTYRS,and95%of cellswerepositive after
7 days of differentiation (Figure 4G). Furthermore, we differenti-
atedp-iNC intomesenchymal lineages, resulting in typical cellular
morphology (Figure 4H) and expression of traditional mesen-
chymal cell surface markers (CD44 and CD73) (Figure 4I). We
also found that p-iNC-derived mesenchymal cells could give
rise into adipogenic, chondrogenic, osteogenic, and smooth
muscle cells (Figures 4J–4M).
After injection of GFP-labeled p-iNC into the intersomite region
of chick embryos, most of the cells had migrated and were tar-
geted to DRG (Figure 4N) and SG, and few cells were targeted
into the developing gut region (Figure 4O, total counted iNC
number = 551). Because of small numbers of cells that localizedibroblasts into iNCs
uction of human postnatal fibroblasts (GM00498).
derived from postnatal fibroblasts, iNC derived from Sox10::eGFP fibroblasts
g the current-voltage curve (I-V curve, D) and the action potentials, upon high
riaxin (PRX), and MPZ.
ith TYRS and MITF antibodies.
pical morphology (H) and surface marker expression (CD44 and CD73) (I).
s (L), and smooth muscle cells (M).
d TUJ1.
ostnatal CD34+ iNC with expression of putative enteric neuron markers (TUJ1,
l iNC clones (Q and R), based on GFP and lineage marker coexpression (S).
elanocytes, respectively.
that of control fibroblasts.
onor fibroblasts. In contrast, in CD34+ iNCs from FD patient fibroblasts, WT
RT-PCR data show a significant difference in WT IKBKAP expression between
duct is shown in the right side of each gel image. n = 3–7.
cale bars correspond to 50 mm for panels (C)–(G) (except for Synapsin, which
ll Stem Cell 15, 497–506, October 2, 2014 ª2014 Elsevier Inc. 503
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GFP-labeled p-iNC to confirm their ability to differentiate and
migrate into the enteric nervous system. After coculture, GFP-
labeled p-iNC cells were distributed around both myenteric
and submucosal plexuses, as confirmed by immunostaining
with TUJ1, VIP, and nNOS (Figure 4P). To find the multipotency
of individual p-iNC cells, we performed single-cell analysis as
shown in Figure 3U. A total of 30 clones of single CD34+ iNC cells
from postnatal fibroblasts were analyzed (two independent re-
peats). Upon staining with GFP and lineage marker antibodies
(Figures 4Q and 4R), we learned that 20% of single iNC clones
from postnatal fibroblasts could become four different lineages
(multipotent or quadpotent) (Figure 4S), whereas 40% of single
iNC clones from postnatal fibroblasts are competent to become
three lineages (tripotent), which is comparable to that of
SOX10::eGFP+ iNC (Figures 3V–3X).
To evaluate whether iNCs from familial dysautonomia (FD)
patient fibroblasts show characteristics similar to those in our
previous hiPSC-based study (Lee et al., 2009), we isolated
CD34+ cells after iNC induction from two different FD fibroblasts
(GM04959 and GM04589) (Figures S4K–S4I). Although the per-
centage of CD34+ cells in FD patient fibroblasts (2.403% ±
0.3051%, n = 9) (at Day 14 of iNC induction) was a significantly
(p = 0.0006) lower than that of healthy donor fibroblasts
(4.769% ± 0.4494%, n = 11) (Figure 4T), we found remarkable
enrichment of NC marker gene expression (Figure S4I, lower
panel). To examine the transcriptional similarity of CD34+ iNCs
at the single-cell level, we profiled gene expression levels of
NC markers using our single-cell quantitative RT-PCR with
each FACS-purified CD34+ iNC (Figure S4M). Most of the single
cells in the FACS-purified CD34+ iNCs population showed
robust expression of NC marker genes. These data suggest
that CD34 can enrich the iNC populations derived from postnatal
fibroblasts, and that isolated CD34+ iNCs obtain an NC gene
expression and transcriptional profile similar to those of hESC-
NC, but not similar to those of postnatal human fibroblasts or
undifferentiated hESCs.
A single point mutation in the IKBKAP (also known as ELP1, a
subunit of Elongator complex) gene lowers the level of wild-type
IKBKAP expression, as shown in postmortem FD patient sam-
ples (Slaugenhaupt et al., 2001) and our hiPSC-based study
(Lee et al., 2009). In our current study, we confirmed that
CD34+ iNCs converted from FD fibroblasts show significantly
decreased levels of wild-type IKBKAP expression, as shown in
the representative gel image of IKBKAP splicing levels ascer-
tained via RT-PCR and qRT-PCR (p < 0.0001) (Figures 4U and
4V). Furthermore, to investigate potential disease mechanisms
underlying FD, we performed a comparative transcriptome anal-
ysis with FACS-purified CD34+ FD-iNCs (two genotypes) versus
control-iNCs (CTRL-iNCs) (two genotypes), and expression
levels of key transcripts from the microarray study were con-
firmed by qPCR analysis (Figure S4L). Intriguingly, we found
that the expression levels of 412 transcripts (among 36,000
probe sets) are decreased in FD-iNCs versus control-iNCs
(fold-change R2-fold; corrected p = 0.05), and about one-third
of the downregulated genes (36.2%) in FD-hiPSC-derived NC
(Lee et al., 2009) are also found in the list of downregulated genes
of FD-iNCs. Importantly, gene ontology analysis (using the
DAVID web-based program for functional annotation analysis;504 Cell Stem Cell 15, 497–506, October 2, 2014 ª2014 Elsevier Inc.http://david.abcc.ncifcrf.gov) revealed that commonly downre-
gulated genes (191 transcripts) in both the current FD-iNC study
and our previous FD-hiPSC-based study (Lee et al., 2009) were
significantly linked to alternative splicing (p = 0.0002094, 98
transcripts, 52.12%) and cell migration (p = 0.0000586, 17 tran-
scripts, 9.04%). The FD-specific cell migration defect was repre-
sented in our previous FD-hiPSC study as well as other studies
(Close et al., 2006), but the involvement of alternative splicing
(except for the IKBKAP gene) has not been discussed in FD
studies. First, to confirm a disease-related migration pheno-
types, a transwell assay was performed with freshly purified
CD34+ FD-iNCs (two different genotypes; FD-iNC 1: GM04959
and FD-iNC 2: GM02341) that showed significantly decreased
migratory ability over that of CD34+ control iNC (GM05756), as
shown in Figure 4W and Figure S4N. To further examine splicing
aberrations, we designated primer sets for RT-PCR of two
different genes, MEF2C (Hakim et al., 2010) and PAX3 (Parker
et al., 2004), and we found alternatively spliced forms in FD-
iNCs (in both GM04959 and GM02341) (Figure 4X), while the
expression levels of the housekeeping gene (GAPDH) were com-
parable (data not shown) between CTRL-iNCs and FD-iNCs. In
MEF2C transcripts of FD-iNC, the gamma region between
exon 9 and exon 10 is skipped, though it was included in
CTRL-iNC (Figure S4O). For the PAX3 transcripts a different
type of isoform D was found in FD-iNC (Figure S4O). All the
PCR products are verified by sequencing (data not shown), sug-
gesting a potential role for an altered splicing in FD pathogen-
esis. Importantly, we found that FD-specific hiPSC-derived NC
population also exhibits splicing aberrations in PAX3 and
MEF2C similar to those of FD-iNC (Figure S4P). These data
show that our aberrant splicing events in PAX3 andMEF2c tran-
scripts are indeed a unique feature in the NC cell type, demon-
strating the feasibility of direct conversion of human postnatal
fibroblasts into iNC populations.
DISCUSSION
Here we show that NC identity can be directly acquired from hu-
man fibroblasts by the delivery of a single transcription factor
(SOX10) and cell-extrinsic cues (Figures 1A–1D and Figures
S1K–S1M), as determined by morphological (Figures 1F–1G
and Figure S1Q), molecular (Figure 1G, Figure 2, and Figures
S2A and S2B), and cellular (Figure 3 and Figure S3) analysis.
Furthermore, by using a cell surface marker (CD34), we could
prospectively isolate the iNC populations directly converted
from human postnatal fibroblasts (Figure 4A and Figure S4I).
As a proof of principal, patient-specific iNCs were achieved
from FD patient fibroblasts (Figures S4I–S4K), exhibiting dis-
ease-relevant characteristics, such as decreased level of direct
conversion efficiency, transcriptional misregulation (IKBKAP
and other transcripts), defective migration ability (Lee et al.,
2009), and previously unknown altered splicing events (Figures
4T–4X and Figures S4L–S4P).
Although SOX10 is a transcription factor related to NC and
oligodendrocyte development, we could not detect any gene
expression of oligodendrocyte markers (Figure S2B). This finding
can be explained by the important role of cell extrinsic cues (e.g.,
the WNT pathway in NC formation) (Garcı´a-Castro et al., 2002),
such as the critical function of Chir99021 during iNC induction
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Derivation of Human Induced Neural Crest(Figures 1D and 1G). In contrast, additional BMP activation ham-
pers the direct conversion process toward iNC fate (Figure S1U).
Our current study demonstrates that environmental cues along
with cell intrinsic factors could play important roles in iNC fate
determination, which should be applicable to other direct con-
version studies.
Disease-specific iNC provides an opportunity for understand-
ing previously unknown disease mechanisms of NC disorders
such as FD. First, we found that FD fibroblasts have reduced
efficiency on iNC direct conversion, which might be explained
by other group’s study that IKBKAP protein and other subunits
of Elongator complex are involved in the demethylation process
(Okada et al., 2010). Our current study demonstrates that FD-
iNC showed decreased migration ability (Figure 4W and Fig-
ure S4N) and alternative splicing (Figure 4X and Figure S4O) in
transcripts of MEF2C (Hakim et al., 2010) and PAX3 (Parker
et al., 2004). The expression levels of these genes are closely
linked to NC lineages (Wang et al., 2006), Waardenburg syn-
drome (Pingault et al., 2010), and a neuromuscular disorder
(Bachinski et al., 2010). Abnormal splicing events might be
related to the role of IKBKAP protein, which binds to unspliced
pre-mRNA (Gilbert et al., 2004), and it is plausible to hypothesize
that the impaired Elongator-RNA interaction directly or indirectly
compromises the general splicing machinery, which remains to
be proven. Going forward, it would be intriguing to compare
the results of the our hiPSC and current iNC studies with those
of NC derived from preimplantation genetic diagnosis (PGD)
embryo-derived hESC lines with the IKBKAP mutation.
Collectively, by employing a single genetic factor and multiple
environmental cues, postnatal fibroblasts of both healthy donors
and patients can be directly converted into a functional and
multipotent iNC cell population that exhibits disease-relevant
phenotypes.
EXPERIMENTAL PROCEDURES
Detailed procedures can be found in the Supplemental Experimental
Procedures.
Fibroblasts
Sox10::eGFP BAC-transformed hESCs were differentiated into fibroblasts
using 10% serum containing MEM (Invitrogen) and maintained for 12 weeks.
The postnatal fibroblasts from healthy donors (GM00498 and GM05756) and
FD patients (GM04589 and GM04959) were purchased from Coriell.
iNC Induction
To induce iNC populations, 1 3 105 cells/well were plated in 12-well tissue
culture plates after FN/Lam or indicated cellular matrix coating. After 24 hr,
cells were treated with 1 uM of 5-Aza (Sigma), 1 mM of VPA (Stemgent), or
TrichostatinA (Sigma) in 1 mg/ml DOX (Sigma) containing Neurobasal medium
for 24 hr. Then, fresh Neurobasal medium containing 1 mg/ml of DOX was
added with 3 uM of Chir99021 (Tocris). At Day 14 of induction, FACS analysis
or FACS sorting was performed.
Ex Vivo Gut/iNC Coculture
Developing chicken guts were taken from chick embryos (H&H Stage 35–38)
and cocultured with GFP-labeled iNCs in Neurobasal medium on the low
attachment surface plate for 24 hr. Then, embryonic guts were vigorously
washed with PBS and cultured with Neurobasal medium containing 20 ng/ml
of BDNF, 20 ng/ml of GDNF, and 200 nM of ascorbic acid for 10–14 days.
Cryosectioned guts were stained following the IHC protocol. For RA treatment,
we used 1 uM RA for FACS-purified iNC (for 24 hr) before coculture.CeSUPPLEMENTAL INFORMATION
Supplemental Information for this article includes four figures, Supplemental
Experimental Procedures, and one table and can be found with this article
online at http://dx.doi.org/10.1016/j.stem.2014.07.013.
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